![](/images/general/no_picture/200_user.png)
Stephen J Ralis
Examiner (ID: 305, Phone: (571)272-6227 , Office: P/3992 )
Most Active Art Unit | 3742 |
Art Unit(s) | 3742, 3992 |
Total Applications | 473 |
Issued Applications | 183 |
Pending Applications | 46 |
Abandoned Applications | 243 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16296243
[patent_doc_number] => 20200281966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => Selenium Disulfide Compositions for Use in Treating Meibomian Gland Dysfunction
[patent_app_type] => utility
[patent_app_number] => 16/093615
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093615
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093615 | Selenium disulfide compositions for use in treating meibomian gland dysfunction | Apr 12, 2017 | Issued |
Array
(
[id] => 12058562
[patent_doc_number] => 20170334905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'NOVEL COMPOSITIONS, USES AND METHODS FOR MAKING THEM'
[patent_app_type] => utility
[patent_app_number] => 15/485106
[patent_app_country] => US
[patent_app_date] => 2017-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36638
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15485106
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/485106 | Compositions, uses and methods for making them | Apr 10, 2017 | Issued |
Array
(
[id] => 17177300
[patent_doc_number] => 11154529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Phosphaplatin liquid formulations
[patent_app_type] => utility
[patent_app_number] => 16/091873
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 9488
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091873
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091873 | Phosphaplatin liquid formulations | Apr 4, 2017 | Issued |
Array
(
[id] => 13077017
[patent_doc_number] => 10058563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => System and method for diagnosis and treatment
[patent_app_type] => utility
[patent_app_number] => 15/478368
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 32284
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/478368 | System and method for diagnosis and treatment | Apr 3, 2017 | Issued |
Array
(
[id] => 11954635
[patent_doc_number] => 20170258786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'RBP4 ANTAGONISTS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/471208
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11655
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471208
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471208 | RBP4 ANTAGONISTS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE | Mar 27, 2017 | Abandoned |
Array
(
[id] => 12105178
[patent_doc_number] => 09861643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-09
[patent_title] => 'System and method for diagnosis and treatment'
[patent_app_type] => utility
[patent_app_number] => 15/471123
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 25906
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471123
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471123 | System and method for diagnosis and treatment | Mar 27, 2017 | Issued |
Array
(
[id] => 16504692
[patent_doc_number] => 20200383948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/089276
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089276 | Pharmaceutical combinations for the treatment of cancer | Mar 27, 2017 | Issued |
Array
(
[id] => 16341599
[patent_doc_number] => 20200306249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => MEDICAMENT
[patent_app_type] => utility
[patent_app_number] => 16/089533
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089533
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089533 | Medicament | Mar 26, 2017 | Issued |
Array
(
[id] => 11969769
[patent_doc_number] => 20170273924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'VALPROATE AS A TOPICAL ANTI-FUNGAL TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/467960
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7426
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467960
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467960 | Valproate as a topical anti-fungal treatment | Mar 22, 2017 | Issued |
Array
(
[id] => 12157261
[patent_doc_number] => 20180028526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'NALMEFENE FOR REDUCTION OF ALCOHOL CONSUMPTION IN SPECIFIC TARGET POPULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/466024
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12671
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15466024
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/466024 | Nalmefene for reduction of alcohol consumption in specific target populations | Mar 21, 2017 | Issued |
Array
(
[id] => 16310716
[patent_doc_number] => 20200289454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => USE OF BENZOFURAN LIGNANS TO INDUCE IL-25 EXPRESSION AND SUPPRESS MAMMARY TUMOR METASTASIS
[patent_app_type] => utility
[patent_app_number] => 16/087093
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087093 | Use of benzofuran lignans to induce IL-25 expression and suppress mammary tumor metastasis | Mar 16, 2017 | Issued |
Array
(
[id] => 12465999
[patent_doc_number] => 09987239
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-06-05
[patent_title] => Pharmaceutical retinoid preparation for topical use
[patent_app_type] => utility
[patent_app_number] => 15/458071
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7570
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458071
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458071 | Pharmaceutical retinoid preparation for topical use | Mar 13, 2017 | Issued |
Array
(
[id] => 17133646
[patent_doc_number] => 11135180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Composition and methods for stimulating clearance of amyloid-beta protein
[patent_app_type] => utility
[patent_app_number] => 16/084067
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10508
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084067 | Composition and methods for stimulating clearance of amyloid-beta protein | Mar 9, 2017 | Issued |
Array
(
[id] => 16341615
[patent_doc_number] => 20200306265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/083339
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083339
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083339 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | Mar 7, 2017 | Abandoned |
Array
(
[id] => 13925945
[patent_doc_number] => 20190046488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => ANTIMICROBIAL COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/078735
[patent_app_country] => US
[patent_app_date] => 2017-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -117
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078735 | Antimicrobial compositions and uses thereof | Feb 20, 2017 | Issued |
Array
(
[id] => 17073733
[patent_doc_number] => 11110112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Methods for the use of 5'-adenosine diphosphate ribose (ADPR)
[patent_app_type] => utility
[patent_app_number] => 15/999269
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 15
[patent_no_of_words] => 19518
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999269
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999269 | Methods for the use of 5'-adenosine diphosphate ribose (ADPR) | Feb 16, 2017 | Issued |
Array
(
[id] => 13982085
[patent_doc_number] => 20190060200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => PERSONAL CARE COMPOSITIONS AND METHODS FOR USING SUCH COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/075784
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/075784 | Personal care compositions and methods for using such compositions | Feb 15, 2017 | Issued |
Array
(
[id] => 17118678
[patent_doc_number] => 11129786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => Sulfate-free personal care compositions and methods for using such compositions
[patent_app_type] => utility
[patent_app_number] => 16/075780
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7734
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/075780 | Sulfate-free personal care compositions and methods for using such compositions | Feb 15, 2017 | Issued |
Array
(
[id] => 11704490
[patent_doc_number] => 20170172989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'TREATMENT OF CANCERS HAVING RESISTANCE TO CHEMOTHERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/434656
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9584
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15434656
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/434656 | TREATMENT OF CANCERS HAVING RESISTANCE TO CHEMOTHERAPEUTIC AGENTS | Feb 15, 2017 | Abandoned |
Array
(
[id] => 11834598
[patent_doc_number] => 20170216317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/431312
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25386
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431312
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/431312 | Combination therapies and methods of use thereof for treating cancer | Feb 12, 2017 | Issued |